Skip to main content

Table 1 Baseline characteristics of all patients depending on department (cardiology or cardiogeriatrics)

From: Good performance in the management of acute heart failure in cardiogeriatric departments: the ICREX-94 experience

Department

Overall

Cardiogeriatrics

Cardiology

p

N (%)

308

66 (21.4)

242 (78.6)

 

Age, yrs.

75.8 ± 13.5

82.4 ± 9.2

74.0 ± 13.8

< 0.001

Age classes, n(%)

   

< 0.001

  < 45 yrs.

9 (2.9)

0 (0)

9 (3.7)

 

 45–74 yrs.

125 (40.6)

12 (16.7)

114 (47.1)

 

 75–85 yrs.

98 (31.8)

26 (39.4)

72 (29.7)

 

  > 85 yrs.

76 (24.6)

28 (42.4)

48 (19.8)

 

Female Gender, n(%)

133 (43.3)

32 (49.2)

101 (41.7)

 

Live alone, n(%)

54 (17.5)

24 (36.4)

30 (12.4)

< 0.001

Married, n(%)

70 (22.7)

14 (21.2)

56 (23.1)

0.869

Live with family, n(%)

31 (10.1)

6 (9.1)

25 (10.3)

1

Live in institution, n(%)

3 (1)

3 (4.5)

0

0.009

IDH

0.6 ± 0.1

0.6 ± 0.1

0.54 ± 0.1

< 0.001

Coronary heart disease, n(%)

115 (37.8)

23 (35.4)

92 (38.5)

0.668

Amyloidosis, n(%)

28 (9.2)

1 (1.5)

27 (11.2)

0.014

Hypertension, n(%)

207 (67.9)

44 (67.7)

163 (67.9)

1

Diabetes, n(%)

112 (36.7)

17 (26.2)

95 (39.6)

0.059

Smoker, n(%)

38 (12.5)

8 (12.3)

30 (12.5)

1

Chronic alcohol intake, n(%)

23 (7.5)

5 (7.7)

18 (7.5)

1

Chronic kidney disease, n(%)

141 (46.2)

27 (41.5)

114 (47.5)

0.404

COPD, n(%)

65 (21.3)

14 (21.5)

51 (21.2)

1

History of heart failure, n(%)

203 (66.8)

43 (66.1)

160 (66.9)

1

Stroke, n(%)

47 (15.4)

13 (20)

34 (14.2)

0.25

Atrial fibrillation, n(%)

181 (59.3)

38 (58.5)

143 (59.6)

0.888

Dementia, n(%)

24 (7.9)

20 (13.6)

11 (4.68)

< 0.001

Depression, n(%)

15 (4.9)

9 (13.6)

6 (2.5)

0.001

BMI, kg/m2

27.1 ± 7.2

26.2 ± 6.6

27.2 ± 7.3

0.03

SBP, mmHg

122 ± 20

122 ± 18

123 ± 22

0.855

LVEF classes, n(%)

   

0.584

  > 50%

69 (22.4)

13 (19.7)

56 (23.1)

 

 40–50%

53 (17.2)

14 (21.2)

39 (16.1)

 

  < 40%

186 (60.4)

39 (59.19)

147 (60.7)

 

BNP at discharge, pg/ml

554 ± 745

618 ± 823

300 ± 112

0.001

Length of stay, days

12.7 ± 10.1

19.3 ± 15.4

11.2 ± 7.3

< 0.001

Creatinemia at discharge, days

134 ± 63

118 ± 38

137 ± 67

0.18

Prescription at discharge, n(%)

292 (95.74)

63 (95.45)

229 (95.82)

0.254

ACEi, n(%)

133 (43.9)

34 (53.1)

99 (41.4)

0.118

ACEisup50, n(%)

53 (17.5)

12 (18.7)

41 (17.1)

0.853

ARNi, n(%)

25 (8.2)

5 (7.8)

20 (8.3)

1

ARNisup50, n(%)

13 (4.3)

5 (7.8)

8 (3.3)

0.157

Diuretic, n(%)

259 (85.2)

51 (79.7)

208 (86.7)

0.169

Dose Diuretic, n(%)

118 ± 190

71 ± 117

131 ± 204

0.002

Beta blocker, n(%)

208 (68.4)

46 (71.9)

162 (67.5)

0.548

Beta blockersup50, n(%)

83 (27.3)

14 (21.9)

69 (28.7)

0.344

MRA, n(%)

61 (20.1)

7 (10.9)

54 (22.5)

0.052

MRAsup50, n(%)

45 (14.8)

6 (9.4)

39 (16.2)

0.234

Ivabradine, n(%)

7 (2.3)

2 (3.1)

5 (2.1)

0.641

LCZ696, n(%)

25 (8.2)

5 (7.8)

20 (8.3)

1

Pacemaker, n(%)

41 (13.4)

16 (24.2)

25 (10.4)

0.007

ICD, n(%)

43 (14.1)

2 (3)

41 (17.1)

0.002

Well Treated, n(%)

24 (7.9)

36 (56.2)

118 (49.2)

0.328

  1. Note. The data are quoted as the number (%), or mean ± sd, "well treated" was defined when patients were treated with BB+ACEi or ARNi
  2. Abbreviations: ACEi Angiotensin-Converting Enzyme inhibitors, ARNi Angiotensin Receptor Neprilysin inhibitor, BMI Body Mass Index, COPD Chronic Obstructive Pulmonary Disease, HDI Human Development Index, HF Heart Failure, HR Heart Rate, ICD Implantable Cardioverter Defibrillator, MRA Mineralocorticoid Receptor Antagonists, SBP Systolic Blood Pressure, LVEF Left Ventricular Ejection Fraction